Global Renal Profile Market, By Indication (Hypertension, Diabetes, Obesity, Family History of Kidney Disease), Test Type (Albumin, Calcium, Carbon Dioxide, Creatinine, Chloride, Glucose, Phosphorous, Potassium, Sodium, BUN, Calculated Anion Gap Value), Process (Quantitative Chemiluminescent Immunoassay, Quantitative Enzyme-Linked Immunosorbent Assay), End User (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes) – Industry Trends and Forecast to 2029.
Renal Profile Market Analysis and Size
According to the WHO, cancer ranked as the second highest cause of death globally in 2018. Additionally, it is predicted that 9.8 million people worldwide died from cancer in 2018, accounting for 1 out of every 6 fatalities. According to the WHO, behavioural and dietary risk factors such as a poor intake of fruits and vegetables, a high body mass index, and a lack of physical exercise are responsible for one-third of all cancer-related deaths.
Data Bridge Market Research analyses that the renal profile market which was USD 800 million in 2021, would rocket up to USD 1324.00 million by 2029, and is expected to undergo a CAGR of 6.50% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Renal Profile Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indication (Hypertension, Diabetes, Obesity, Family History of Kidney Disease), Test Type (Albumin, Calcium, Carbon Dioxide, Creatinine, Chloride, Glucose, Phosphorous, Potassium, Sodium, BUN, Calculated Anion Gap Value), Process (Quantitative Chemiluminescent Immunoassay, Quantitative Enzyme-Linked Immunosorbent Assay), End User (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), Akers Biosciences, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific (Luxembourg), Boston Heart Diagnostics Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Home Access Health (U.S.), Laboratory Corporation of America Holdings (U.S.), PRIMA Lab SA (Switzerland), Quest Diagnostics Incorporated (U.S.), Randox Laboratories Ltd. (U.K.), Sekisui Diagnostics (U.S.), Siemens (Germany), Merck KGaA (Germany)
|
|
Market Opportunities
|
|
Market Definition
A test to evaluate kidney health is called a renal profile. The renal profile shows blood urea, potassium, sodium, calcium, chloride, and creatinine levels. A few laboratories also figure the glomerular filtration rate.
Global Renal Profile Market Dynamics
Drivers
- Rising healthcare expenditure
Rising geriatric population, increasing alcohol preferences and consumption, changing lifestyles that will cause hypertension and diabetes, and increasing patient volume for kidney disorders globally are some of the factors that are predicted to increase the growth of the renal profile market from 2022 to 2029.
- Technological Innovations
Rising innovation and technological advancement which is the first systems for treating kidney failure were developed in the 1940's, when it was found that blood could be successfully cleared of toxins and returned to the body using a relatively simple device based on artificial sausage skin wrapped around a wooden frame) will further increase the number of prospects that will drive the growth of the renal profile market throughout the forecast period.
- Rising chronic diseases
The market for renal profile will expand at a CAGR of 6.50%, over the forecast period. The rising prevalence of kidney illness is one of the main drivers of the global market for renal profile. Globally, the prevalence of various co-morbidities is increasing, as is the general population. Increased prevalence of chronic conditions including diabetes, high blood pressure, and obesity also helps the industry grow.
Opportunities
- Increase in the number of research and development activities
Renal biomarkers are typically employed in preclinical and clinical studies to evaluate the safety of novel medications, therefore growing spending in research and development will also contribute to market growth. Furthermore, the use of renal profile is being driven by the rising need for clinical diagnosis in the early stages of cancer.
Restraints/Challenges
- Lack of reimbursement policies
On the other hand, the unfavourable policies of the insurance companies and reforms will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the renal profile market.
This renal profile market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the renal profile market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Renal Profile Market
Coronavirus disease (COVID-19) causes many deleterious effects throughout the body. Prior studies show that the incidence of acute kidney injury in COVID-19 patients could be as high as 25%. The COVID-19 epidemic has rarely had an impact on the market for renal profile worldwide. Therefore, the COVID-19 epidemic in the UK interrupts the worldwide supply chain and has a detrimental effect on the market for renal profile. And throughout the forecast period, the market is anticipated to expand more quickly.
Global Renal Profile Market Scope
The renal profile market is segmented on the basis of indication, test type, process and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Hypertension
- Diabetes
- Obesity
- Family History of Kidney Disease
Test Type
- Albumin
- Calcium
- Carbon Dioxide
- Creatinine
- Chloride
- Glucose
- Phosphorous
- Potassium
- Sodium
- BUN
- Calculated Anion Gap Value
Process
- Quantitative Chemiluminescent Immunoassay
- Quantitative Enzyme-Linked Immunosorbent Assay
End User
- Hospitals
- Diagnostic Laboratories
- Research Laboratories and Institutes
Renal Profile Market Regional Analysis/Insights
The renal profile market is analysed and market size insights and trends are provided by country, indication, test type, process and end user as referenced above.
The countries covered in the renal profile market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the renal profile market due to the rising occurrences of chronic diseases and hypertension along with rising awareness among the people regarding kidney diseases and their treatment.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing number of geriatric population and rising cases of kidney disorders.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Renal Profile Market Share Analysis
The renal profile market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to renal profile market.
Some of the major players operating in the renal profile market are:
- Abbott (U.S.)
- Akers Biosciences, Inc. (U.S.)
- Beckman Coulter, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- Boston Heart Diagnostics Corporation (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Home Access Health (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- PRIMA Lab SA (Switzerland)
- Quest Diagnostics Incorporated (U.S.)
- Randox Laboratories Ltd. (U.K.)
- Sekisui Diagnostics (U.S.)
- Siemens (Germany)
- Merck KGaA (Germany)
SKU-